San Diego Business Journal

Two Local Biotechs Announce Positive Clinical Data, Stocks Soar

Biotechnology Column By Meghana Keshavan Monday, July 8, 2013

Announcing positive clinical data can have a critical effect on a biotech’s stock value — as evidenced recently Halozyme Therapeutics Inc...


Page 1 of 2.

Take 1 minute to subscribe and you’ll get this story immediately, plus:

Already a subscriber? Sign in

  • 51 weekly issues: $153 value
  • Subscriber-only digital content every business day, plus full access to archives: $150 value
  • Book of Lists — the biggest, hottest companies in San Diego: $75 value
  • NEW: San Diego 500 — influential business leaders you need to know: $50 value
  • Total Package Value: $428

Yours for only $129